News

Similarly, differences between rivaroxaban or edoxaban and antiplatelets in stroke are also likely small. In these people, the risk of serious bleeding is probably increased with rivaroxaban; however, ...
The exposure of edoxaban was similar when combined with enzalutamide, however the 90% CI fell outside of the 0.8-1.25 range (AUC 0–24h GMR 1.03; 90% CI 0.78 – 1.35). No adverse events were reported ...
Medically reviewed by Jeffrey S. Lander, MD There are many types and combinations of drugs used to treat a myocardial infarction (MI), also known as a heart attack. These drugs can help prevent blood ...
Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to ...
CHICAGO, IL—Following bioprosthetic valve surgery, anticoagulation with edoxaban (Savaysa; Daiichi Sankyo) is as effective as warfarin, although this strategy might come at a higher cost of bleeding, ...
Edoxaban monotherapy reduced net adverse clinical events compared with edoxaban plus a single antiplatelet agent, when used as long-term antithrombotic therapy, in patients with high-risk atrial ...
In the EPIC-CAD trial, edoxaban monotherapy was associated with better net clinical benefit than edoxaban plus a single antiplatelet agent, when given as long-term antithrombotic therapy, in ...
Very elderly people with nonvalvular atrial fibrillation (Afib) got the same stroke prevention benefits from edoxaban (Savaysa) and apixaban (Eliquis), though one drug was associated with more ...
Data from more than 13,000 patients with AF show that the use of edoxaban over four years is associated with a low annualised rate of all-cause death, ischaemic stroke and major bleeding.1,2 The ...
Once-daily edoxaban seems safe and effective for pediatric patients with cardiac disease, according to a study presented at the American Heart Association Scientific Sessions 2022, held from Nov ...